Active Ingredients: Each tablet contains ephedrine hydrochloride USP “bronchodilator”, 12.5 mg and guaifenesin USP “expectorant”, 200 mg. Contraindications: During or within 14 days of MAOIs. Warnings/Precautions: Asthma associated hospitalization. Cardiac disease. Hypertension. Diabetes. Thyroid disease. Seizures. Narrow angle glaucoma. Psychoses. GI or GU obstruction. Consult medical advice if symptoms worsen or do not improve within 60mins, or need 12 tabs in any day, or use >8 tabs/day for more than 3 days/week, or have >2 asthma attacks/week. Pregnancy. Nursing mothers. Interactions: Avoid caffeine-containing products, stimulant dietary supplements. Caution with other sympathomimetics (eg, phenylephrine, pseudoephedrine, ephedrine), weight control agents, antidepressants, sedatives. Pharmacological Class: Sympathomimetic + expectorant. Adverse Reactions: Nervousness, insomnia, tachycardia, tremor, seizure.